Precision medicine in MASLD: Integrating genetics, multi-omics, and artificial intelligence for risk stratification and targeted therapy.
The remaining challenges and research priorities needed to integrate precision hepatology into routine care are outlined, highlighting the identification of clinically actionable MASLD subtypes and the equitable translation of findings into improved long-term outcomes.